JP2022548575A5 - - Google Patents
Info
- Publication number
- JP2022548575A5 JP2022548575A5 JP2022515966A JP2022515966A JP2022548575A5 JP 2022548575 A5 JP2022548575 A5 JP 2022548575A5 JP 2022515966 A JP2022515966 A JP 2022515966A JP 2022515966 A JP2022515966 A JP 2022515966A JP 2022548575 A5 JP2022548575 A5 JP 2022548575A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025159217A JP2026016387A (ja) | 2019-09-11 | 2025-09-25 | 切替え療法によるｒｍｓの治療 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19196789.2 | 2019-09-11 | ||
| EP19196789 | 2019-09-11 | ||
| EP20154736 | 2020-01-30 | ||
| EP20154736.1 | 2020-01-30 | ||
| PCT/EP2020/075332 WO2021048280A1 (en) | 2019-09-11 | 2020-09-10 | Treatment of rms by switching therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025159217A Division JP2026016387A (ja) | 2019-09-11 | 2025-09-25 | 切替え療法によるｒｍｓの治療 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022548575A JP2022548575A (ja) | 2022-11-21 |
| JP2022548575A5 true JP2022548575A5 (https=) | 2023-09-13 |
| JPWO2021048280A5 JPWO2021048280A5 (https=) | 2023-09-13 |
| JP7794735B2 JP7794735B2 (ja) | 2026-01-06 |
Family
ID=72709332
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022515966A Active JP7794735B2 (ja) | 2019-09-11 | 2020-09-10 | 切替え療法によるｒｍｓの治療 |
| JP2025159217A Pending JP2026016387A (ja) | 2019-09-11 | 2025-09-25 | 切替え療法によるｒｍｓの治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025159217A Pending JP2026016387A (ja) | 2019-09-11 | 2025-09-25 | 切替え療法によるｒｍｓの治療 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20220298253A1 (https=) |
| EP (2) | EP4230655A3 (https=) |
| JP (2) | JP7794735B2 (https=) |
| KR (1) | KR20220062025A (https=) |
| CN (3) | CN118436777A (https=) |
| AU (1) | AU2020344154A1 (https=) |
| CA (1) | CA3150947A1 (https=) |
| DK (1) | DK3864053T3 (https=) |
| ES (1) | ES2957112T3 (https=) |
| FI (1) | FI3864053T3 (https=) |
| IL (1) | IL290619A (https=) |
| LT (1) | LT3864053T (https=) |
| MX (1) | MX2022003010A (https=) |
| SI (1) | SI3864053T1 (https=) |
| WO (1) | WO2021048280A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120053638A (zh) | 2016-08-15 | 2025-05-30 | 诺华股份有限公司 | 使用奥法木单抗治疗多发性硬化的方案和方法 |
| MX2022003030A (es) * | 2019-09-11 | 2022-04-07 | Novartis Ag | Tratamiento de afecciones distintas de la esclerosis multiple en pacientes tratados con ofatumumab. |
| US20230151106A1 (en) * | 2020-04-09 | 2023-05-18 | Novartis Ag | OFATUMUMAB FOR TREATING MS WHILE MAINTAINING SERUM IgG |
| US20240228647A1 (en) * | 2021-04-14 | 2024-07-11 | Novartis Ag | Ofatumumab for treating multiple sclerosis in asian patients |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101928344B (zh) | 2002-10-17 | 2014-08-13 | 根马布股份公司 | 抗cd20的人单克隆抗体 |
| UA107557C2 (xx) | 2007-07-06 | 2015-01-26 | Композиція антитіла офатумумабу | |
| TW201014605A (en) * | 2008-09-16 | 2010-04-16 | Genentech Inc | Methods for treating progressive multiple sclerosis |
| EP2692343A1 (en) * | 2012-08-03 | 2014-02-05 | Forward Pharma A/S | Combination therapy for treatment of multiple sclerosis |
| EA201692180A1 (ru) * | 2014-04-29 | 2017-08-31 | Тева Фармасьютикал Индастриз Лтд. | Лахинимод для лечения пациентов с рецидивирующе-ремиттирующим рассеянным склерозом (рррс) с высоким статусом инвалидизации |
| CN120053638A (zh) | 2016-08-15 | 2025-05-30 | 诺华股份有限公司 | 使用奥法木单抗治疗多发性硬化的方案和方法 |
-
2020
- 2020-09-10 ES ES20785440T patent/ES2957112T3/es active Active
- 2020-09-10 JP JP2022515966A patent/JP7794735B2/ja active Active
- 2020-09-10 LT LTEPPCT/EP2020/075332T patent/LT3864053T/lt unknown
- 2020-09-10 US US17/753,632 patent/US20220298253A1/en active Pending
- 2020-09-10 WO PCT/EP2020/075332 patent/WO2021048280A1/en not_active Ceased
- 2020-09-10 MX MX2022003010A patent/MX2022003010A/es unknown
- 2020-09-10 DK DK20785440.7T patent/DK3864053T3/da active
- 2020-09-10 CA CA3150947A patent/CA3150947A1/en active Pending
- 2020-09-10 CN CN202410529206.7A patent/CN118436777A/zh active Pending
- 2020-09-10 AU AU2020344154A patent/AU2020344154A1/en active Pending
- 2020-09-10 KR KR1020227011366A patent/KR20220062025A/ko active Pending
- 2020-09-10 EP EP23183390.6A patent/EP4230655A3/en active Pending
- 2020-09-10 SI SI202030263T patent/SI3864053T1/sl unknown
- 2020-09-10 EP EP20785440.7A patent/EP3864053B1/en active Active
- 2020-09-10 FI FIEP20785440.7T patent/FI3864053T3/fi active
- 2020-09-10 CN CN202080064158.9A patent/CN114401742B/zh active Active
- 2020-09-10 CN CN202410529209.0A patent/CN118403156A/zh active Pending
-
2022
- 2022-02-14 IL IL290619A patent/IL290619A/en unknown
-
2025
- 2025-09-25 JP JP2025159217A patent/JP2026016387A/ja active Pending